Is Pcom same as PCOS?

The diagnosis of PCOS is based on a combination of clinical, biochemical, and ultrasound criteria, and the main diagnostic criteria of PCOS are polycystic ovarian morphology (PCOM), oligo-anovulation, and hyperandrogenism (HA) [2].

What is morphological PCOS?

Under Rotterdam, polycystic ovary morphology (PCOM) is defined as a follicle number per ovary of ≥ 12 and/or an ovarian volume of >10 cc in at least one ovary. The 2014 Androgen Excess and PCOS Society task force recommended the use of ≥ 25 follicles and/or a volume of >10 cc [15].

What are the symptoms of Pcom?

Ultrasonographic PCOM is a common finding among healthy women. Many of these women have mild PCOS features, that is, irregular menstrual cycles and/or hirsutism.

Can I get pregnant with Pcom?

Polycystic ovarian syndrome, or PCOS, is a common hormonal condition in women. Women with PCOS can struggle to become pregnant and are at higher risk of developing complications during pregnancy. However, by managing the symptoms, many women with PCOS can become pregnant and have a healthy baby.

What is Pcom mean?

Introduction. Polycystic ovarian morphology (PCOM) is one of the criteria used for the diagnosis of polycystic ovarian syn- drome (PCOS) in adult women [1]. In 2003, the Rotter- dam Consensus (RC) defined PCOM as the presence of one ovary with an ovarian volume larger than 10 mL or having more than 12 follicles [2, 3].

What is Pcom?

Is Pcom common?

Context: Polycystic ovarian morphology (PCOM) is present in 25\% of normal women in the absence of polycystic ovary syndrome (PCOS); however, the natural history of PCOM is unknown. Objective: We hypothesized that the presence of PCOM predisposes the development of PCOS.

Does Pcom cause irregular periods?

PCOM was assessed by ultrasound in 54 women (15\%). Patients with severe menstrual pain were more likely to have irregular menstrual cycles (P=0.03) and heavy menstrual flow (P=0.01) than those with mild menstrual pain.

What is the treatment for Pcom?

Pulsatile GnRH seems to be a successful and safe method for ovulation induction in “FHA-PCOM” patients. If results were confirmed by prospective studies, GnRH therapy could therefore become a first-line treatment for this specific population, just as it is for women with FHA without PCOM.